Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Notes Payables (2018 - 2022)

Inspire Medical Systems' Notes Payables history spans 3 years, with the latest figure at $12.2 million for Q2 2022.

  • For Q2 2022, Notes Payables rose 299.93% year-over-year to $12.2 million; the TTM value through Jun 2022 reached $12.2 million, up 299.93%, while the annual FY2021 figure was $9.2 million, N/A changed from the prior year.
  • Notes Payables for Q2 2022 was $12.2 million at Inspire Medical Systems, roughly flat from $12.2 million in the prior quarter.
  • Across five years, Notes Payables topped out at $12.2 million in Q1 2022 and bottomed at $681000.0 in Q1 2018.
  • The 3-year median for Notes Payables is $6.1 million (2021), against an average of $6.6 million.
  • The largest YoY upside for Notes Payables was 299.93% in 2022 against a maximum downside of 299.93% in 2022.
  • A 3-year view of Notes Payables shows it stood at $2.7 million in 2018, then soared by 237.55% to $9.2 million in 2021, then skyrocketed by 33.33% to $12.2 million in 2022.
  • Per Business Quant, the three most recent readings for INSP's Notes Payables are $12.2 million (Q2 2022), $12.2 million (Q1 2022), and $9.2 million (Q4 2021).